Basic fibroblast growth factor and fibroblastic growth factor receptor-1 may contribute to head and neck paraganglioma development by an autocrine or paracrine mechanism

Human Pathology

Volumn 38, Issue 1, 2007, Pages 79-85

  Douwes Dekker, Pieter Bas ^a   Kuipers Dijkshoorn, Nel J ^a   Baelde, Hans J ^a   van der Mey, Andel G L ^a   Hogendoorn, Pancras C W ^a   Cornelisse, Cees J ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Basic fibroblastic growth factor; Carotid body; Fibroblastic growth factor receptor; Hypoxia; Paragangliomas; SDHD

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; FIBROBLAST GROWTH FACTOR 1;

ARTICLE; AUTOCRINE EFFECT; CARCINOGENESIS; CAROTID BODY; CLINICAL ARTICLE; CYTOPLASM; HEAD AND NECK TUMOR; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PARACRINE SIGNALING; PARAGANGLIOMA; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; REAL TIME POLYMERASE CHAIN REACTION; RECEPTOR AFFINITY; STAINING;

ADULT; AUTOCRINE COMMUNICATION; FIBROBLAST GROWTH FACTOR 2; HEAD AND NECK NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; PARACRINE COMMUNICATION; PARAGANGLIOMA; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 1; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 33845294424     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humpath.2006.06.013     Document Type: Article

References (34)

1. Pellitteri P.K., Rinaldo A., Myssiorek D., et al. Paragangliomas of the head and neck. Oral Oncol 40 (2004) 563-575
2. Baysal B.E. Hereditary paraganglioma targets diverse paraganglia. J Med Genet 39 (2002) 617-622
3. Gottlieb E., and Tomlinson I.P. Mitochondrial tumour suppressors: a genetic and biochemical update. Nat Rev Cancer 5 (2005) 857-866
4. Eng C., Kiuru M., Fernandez M.J., and Aaltonen L.A. A role for mitochondrial enzymes in inherited neoplasia and beyond. Nat Rev Cancer 3 (2003) 193-202
5. Gimenez-Roqueplo A.P., Favier J., Rustin P., et al. The R22X mutation of the SDHD gene in hereditary paraganglioma abolishes the enzymatic activity of complex II in the mitochondrial respiratory chain and activates the hypoxia pathway. Am J Hum Genet 69 (2001) 1186-1197
6. Paciga M., and Nurse C.A. Basic FGF localization in rat carotid body: paracrine role in O2-chemoreceptor survival. Neuroreport 12 (2001) 3287-3291
7. Statuto M., Ennas M.G., Zamboni G., et al. Basic fibroblast growth factor in human pheochromocytoma: a biochemical and immunohistochemical study. Int J Cancer 53 (1993) 5-10
8. Clarke M.R., Weyant R.J., Watson C.G., and Carty S.E. Prognostic markers in pheochromocytoma. Hum Pathol 29 (1998) 522-526
9. Nurse C.A., and Vollmer C. Role of basic FGF and oxygen in control of proliferation, survival, and neuronal differentiation in carotid body chromaffin cells. Dev Biol 184 (1997) 197-206
10. Frodin M., and Gammeltoft S. Insulin-like growth factors act synergistically with basic fibroblast growth factor and nerve growth factor to promote chromaffin cell proliferation. Proc Natl Acad Sci U S A 91 (1994) 1771-1775
11. Taschner P.E., Jansen J.C., Baysal B.E., et al. Nearly all hereditary paragangliomas in the Netherlands are caused by two founder mutations in the SDHD gene. Genes Chromosomes Cancer 31 (2001) 274-281
12. Heath D. The human carotid body in health and disease. J Pathol 164 (1991) 1-8
13. Sato T., Wilson T.S., Hughes L.F., Konrad H.R., Nakayama M., and Helfert R.H. Age-related changes in levels of tyrosine kinase B receptor and fibroblast growth factor receptor 2 in the rat inferior colliculus: implications for neural senescence. Neuroscience 103 (2001) 695-702
14. de Boer W.I., Vermeij M., Diez de Medina S.G., et al. Functions of fibroblast and transforming growth factors in primary organoid-like cultures of normal human urothelium. Lab Invest 75 (1996) 147-156
15. Douwes Dekker P.B., Hogendoorn P., Kuipers-Dijkshoorn N., et al. SDHD mutations in head and neck paragangliomas result in destabilization of complex II in the mitochondrial respiratory chain with loss of enzymatic activity and abnormal mitochondrial morphology. J Pathol 201 (2003) 480-486
16. Bovee J.V., van den Broek L.J., Cleton-Jansen A.M., and Hogendoorn P.C. Up-regulation of PTHrP and Bcl-2 expression characterizes the progression of osteochondroma towards peripheral chondrosarcoma and is a late event in central chondrosarcoma. Lab Invest 80 (2000) 1925-1934
17. Baelde H.J., Eikmans M., Doran P.P., Lappin D.W., de Heer E., and Bruijn J.A. Gene expression profiling in glomeruli from human kidneys with diabetic nephropathy. Am J Kidney Dis 43 (2004) 636-650
18. Ross D.T., Scherf U., Eisen M.B., et al. Systematic variation in gene expression patterns in human cancer cell lines. Nat Genet 24 (2000) 227-235
19. Mariman E.C., van Beersum S.E., Cremers C.W., van Baars F.M., and Ropers H.H. Analysis of a second family with hereditary non-chromaffin paragangliomas locates the underlying gene at the proximal region of chromosome 11q. Hum Genet 91 (1993) 357-361
20. Szebenyi G., and Fallon J.F. Fibroblast growth factors as multifunctional signaling factors. Int Rev Cytol 185 (1999) 45-106
21. Khaliq A., Jarvis-Evans J., McLeod D., and Boulton M. Oxygen modulates the response of the retinal pigment epithelium to basic fibroblast growth factor and epidermal growth factor by receptor regulation. Invest Ophthalmol Vis Sci 37 (1996) 436-443
22. Kuwabara K., Ogawa S., Matsumoto M., et al. Hypoxia-mediated induction of acidic/basic fibroblast growth factor and platelet-derived growth factor in mononuclear phagocytes stimulates growth of hypoxic endothelial cells. Proc Natl Acad Sci U S A 92 (1995) 4606-4610
23. Khaliq A., Patel B., Jarvis-Evans J., Moriarty P., McLeod D., and Boulton M. Oxygen modulates production of bFGF and TGF-beta by retinal cells in vitro. Exp Eye Res 60 (1995) 415-423
24. Baysal B.E. On the association of succinate dehydrogenase mutations with hereditary paraganglioma. Trends Endocrinol Metab 14 (2003) 453-459
25. Pennacchietti S., Michieli P., Galluzzo M., Mazzone M., Giordano S., and Comoglio P.M. Hypoxia promotes invasive growth by transcriptional activation of the met protooncogene. Cancer Cell 3 (2003) 347-361
26. Anderson D.J. Molecular control of cell fate in the neural crest: the sympathoadrenal lineage. Annu Rev Neurosci 16 (1993) 129-158
27. Unsicker K., and Westermann R. Basic fibroblast growth factor promotes transmitter storage and synthesis in cultured chromaffin cells. Brain Res Dev Brain Res 65 (1992) 211-216
28. Sieber-Blum M., and Zhang J.M. Growth factor action in neural crest cell diversification. J Anat 191 Pt 4 (1997) 493-499
29. Desire L., Courtois Y., and Jeanny J.C. Endogenous and exogenous fibroblast growth factor 2 support survival of chick retinal neurons by control of neuronal bcl-x(L) and bcl-2 expression through a fibroblast growth factor receptor 1- and ERK-dependent pathway. J Neurochem 75 (2000) 151-163
30. Douwes Dekker P.B., Kuipers-Dijkshoorn N., Hogendoorn P.C., van der Mey A.G., and Cornelisse C.J. G2M arrest, blocked apoptosis, and low growth fraction may explain indolent behavior of head and neck paragangliomas. Hum Pathol 34 (2003) 690-698
31. Selak M.A., Armour S.M., MacKenzie E.D., et al. Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-alpha prolyl hydroxylase. Cancer Cell 7 (2005) 77-85
32. Li J., Shworak N.W., and Simons M. Increased responsiveness of hypoxic endothelial cells to FGF2 is mediated by HIF-1alpha-dependent regulation of enzymes involved in synthesis of heparan sulfate FGF2-binding sites. J Cell Sci 115 (2002) 1951-1959
33. Ogawa T., Takayama K., Takakura N., Kitano S., and Ueno H. Anti-tumor angiogenesis therapy using soluble receptors: enhanced inhibition of tumor growth when soluble fibroblast growth factor receptor-1 is used with soluble vascular endothelial growth factor receptor. Cancer Gene Ther 9 (2002) 633-640
34. Yoshiji H., Kuriyama S., Yoshii J., et al. Synergistic effect of basic fibroblast growth factor and vascular endothelial growth factor in murine hepatocellular carcinoma. Hepatology 35 (2002) 834-842